Login
Calithera Biosciences, Inc. logo

Calithera Biosciences, Inc.

calithera.com

Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.

Financial snapshot data is not available right now.

Stock Price

Loading...
Market Cap: $9.745 Thousand

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support